Correction Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinibresistant gastrointestinal stromal tumours

Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

16:56 EDT 23 May 2019 | Nature Publishing

More From BioPortfolio on "Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours"